Condition
Rare Malignant Neoplasm
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07307053Phase 1Not Yet RecruitingPrimary
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
NCT05581979Completed
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
NCT06119789Phase 2RecruitingPrimary
Precision Cancer Therapy in Rare Cancers
NCT06872853RecruitingPrimary
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
NCT05217407RecruitingPrimary
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
Showing all 5 trials